Relay Therapeutics
IPOTransforming drug discovery
Public · Cambridge, United States · Founded 2015 · $520.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 51–200
- Founded
- 2015
- Business Model
- B2B
- Website
- relaytx.com
- Total Funding
- $520.0M
- Last Round
- $400.0M Series CDec 2018
- Rounds
- 3
- Type
- Public
About
Relay Therapeutics is a clinical-stage precision medicines company that integrates leading-edge computational and experimental technologies through its proprietary Dynamo Platform. The platform models protein motion to identify and drug previously intractable targets. Its pipeline is focused on precision oncology and genetic disease, with multiple programs in clinical development including collaborations with major pharma partners.
Summary
Relay Therapeutics is a Biotech company based in Cambridge, United States, founded in 2015. It has raised $520.0M in total across 3 rounds, most recently a $400.0M Series C round in Dec 2018. Investors include SoftBank, BVF Partners and Third Rock Ventures.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2020
Sign up to see all 4 rounds
Series A through IPO — per-round amounts, valuations, and who invested in each round.
Investors
.png)
Similar Companies
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/relay-therapeutics"><img src="https://indexed.vc/api/badge/company/relay-therapeutics" alt="Relay Therapeutics on Indexed.vc" width="260" height="76" /></a>